1. Home
  2. NNVC vs BTCS Comparison

NNVC vs BTCS Comparison

Compare NNVC & BTCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NNVC

NanoViricides Inc.

HOLD

Current Price

$1.28

Market Cap

24.7M

Sector

Health Care

ML Signal

HOLD

Logo BTCS Inc.

BTCS

BTCS Inc.

HOLD

Current Price

$3.17

Market Cap

148.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNVC
BTCS
Founded
2005
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
24.7M
148.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NNVC
BTCS
Price
$1.28
$3.17
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
334.8K
1.3M
Earning Date
11-14-2025
11-14-2025
Dividend Yield
N/A
1.57%
EPS Growth
N/A
644.42
EPS
N/A
1.76
Revenue
N/A
$11,724,983.00
Revenue This Year
N/A
$248.05
Revenue Next Year
N/A
$41.01
P/E Ratio
N/A
$1.80
Revenue Growth
N/A
464.28
52 Week Low
$0.94
$1.25
52 Week High
$2.23
$8.49

Technical Indicators

Market Signals
Indicator
NNVC
BTCS
Relative Strength Index (RSI) 45.42 48.26
Support Level $1.20 $3.28
Resistance Level $1.31 $3.29
Average True Range (ATR) 0.10 0.24
MACD 0.01 0.01
Stochastic Oscillator 40.48 34.29

Price Performance

Historical Comparison
NNVC
BTCS

About NNVC NanoViricides Inc.

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.

About BTCS BTCS Inc.

BTCS Inc. ("BTCS" or the "Company"), short for Blockchain Technology Consensus Solutions, is a U.S.-based Ethereum-first blockchain technology company committed to driving scalable revenue and ETH accumulation through its hallmark strategy, the DeFi/TradFi Accretion Flywheel, an integrated approach to capital formation and blockchain infrastructure. By combining decentralized finance ("DeFi") and traditional finance ("TradFi") mechanisms with its blockchain infrastructure operations, comprising NodeOps (staking) and Builder+ (block building), BTCS offers one of the most sophisticated opportunities for leveraged ETH exposure, driven by scalable revenue generation and a yield-focused ETH accumulation strategy. Discover how BTCS offers operational and financial leveraged exposure to Ethereum through the public markets at www.btcs.com.

Share on Social Networks: